HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,732 | +2.1% | 1,171 | -3.6% | 0.00% | 0.0% |
| Q2 2023 | $43,825 | +69.5% | 1,215 | +79.5% | 0.00% | 0.0% |
| Q1 2023 | $25,855 | -36.4% | 677 | -5.3% | 0.00% | 0.0% |
| Q4 2022 | $40,684 | +56.5% | 715 | +7.4% | 0.00% | 0.0% |
| Q3 2022 | $26,000 | -21.2% | 666 | -11.0% | 0.00% | 0.0% |
| Q2 2022 | $33,000 | +13.8% | 748 | +4.5% | 0.00% | 0.0% |
| Q1 2022 | $29,000 | +26.1% | 716 | +23.4% | 0.00% | 0.0% |
| Q4 2021 | $23,000 | +4.5% | 580 | +6.4% | 0.00% | 0.0% |
| Q3 2021 | $22,000 | -21.4% | 545 | -12.9% | 0.00% | 0.0% |
| Q2 2021 | $28,000 | +16.7% | 626 | +9.2% | 0.00% | 0.0% |
| Q1 2021 | $24,000 | +4.3% | 573 | +7.5% | 0.00% | 0.0% |
| Q4 2020 | $23,000 | +64.3% | 533 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $14,000 | 0.0% | 533 | +5.8% | 0.00% | 0.0% |
| Q2 2020 | $14,000 | +180.0% | 504 | +99.2% | 0.00% | – |
| Q1 2020 | $5,000 | +400.0% | 253 | +416.3% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 49 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 49 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 49 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |